For citations:
Nesterova E.S., Kravchenko S.K., Kovrigina A.M., Gemdzhian E.G., Plastinina L.V., Mangasarova Ya.K., Babaeva F.E., Misyurina A.E., Margolin O.V., Magomedova A.U., Vorobiev V.I., Maryin D.S., Baryakh E.A., Polyakov Yu.Yu., Zeynalova P.A., Volodicheva E.M., Glonina N.N., Minaeva N.V., Davydova G.A., Savchenko V.G. Follicular lymphoma: results of multicenter study of first-line therapy with bendamustine and rituximab, risk factors for adverse events (fl-rus-2013 protocol). Oncohematology. 2018;13(3):10-24. (In Russ.) https://doi.org/10.17650/1818-8346-2018-13-3-10-24
Email this article 